Location History:
- Mountain View, CA (US) (2020 - 2023)
- Redwood City, CA (US) (2022 - 2023)
Company Filing History:
6 out of 7 
4 out of 5,309 
Years Active: 2020-2025
Title: Spotlight on Inventor Shelley Erin Ackerman from Mountain View, CA
Introduction: Shelley Erin Ackerman, a talented inventor based in Mountain View, CA, has made significant contributions to the field of biotechnology. With an impressive portfolio of 5 patents, Ackerman's innovative work has caught the attention of the industry.
Latest Patents:
1. Anti-Dectin-2 antibodies: Ackerman's invention revolves around dendritic cell-associated C-type lectin 2 (Dectin-2) binding agents, enhancing the understanding of immune responses. This patent introduces novel methods for treating diseases and stimulating antigen-presenting cells.
2. Antibody adjuvant conjugates: Another groundbreaking invention by Ackerman is the development of immunoconjugates that combine antibody constructs with adjuvant moieties to effectively treat cancer. This patent highlights innovative approaches to cancer therapy.
Career Highlights: Ackerman has left a mark on renowned companies like Bolt Biotherapeutics, Inc., and Leland Stanford Junior University. His expertise in the biotech domain has led to the successful implementation of cutting-edge technologies in the medical field.
Collaborations: Ackerman has collaborated with distinguished professionals in the industry, including Michael Nathaniel Alonso and Edgar George Engleman. Together, they have pushed the boundaries of biotechnological research, paving the way for groundbreaking discoveries.
Conclusion: Shelley Erin Ackerman's groundbreaking inventions and collaborations have solidified his position as a pioneering inventor in the biotechnology sector. His persistent dedication to innovation continues to inspire future advancements in the field.